Your session is about to expire
← Back to Search
Respiratory Monitoring Techniques for Neuromuscular Disease
Study Summary
This trial will compare a new breathing monitor (pneuRIP) to an existing one, to measure breathing patterns in 20 children (10 normal, 10 with difficulties).
Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- I have a neuromuscular disease and mild breathing problems.I have severe trouble breathing.I can understand and follow spoken directions.
- Group 1: pneuRIP(breathing with resistance)
- Group 2: Respitrace system (Carefusion) (breathing without resistance)
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
Are individuals within the age range of 55 and above accepted for this clinical research?
"As mandated by the requirements for enrolling in this clinical trial, participants must fall between the ages of 11 and 17."
Is enrollment open for this medical experiment?
"According to clinicaltrials.gov, this experiment has been actively recruiting since it was initially advertised on August 1st 2014 and the listing's content was most recently updated in March 14th 2023."
How can I join this clinical experiment?
"To be eligible for this research project, the subject must have a neuromuscular disorder and fall within an age range of 11 to 17 years. Approximately 20 participants are currently being sought after."
How many people have been enrolled in this research protocol?
"Affirmative. According to information on clinicaltrials.gov, this investigation is actively recruiting patients with 20 participants needed from 1 location. The trial was first published on August 1st 2014 and the latest update occurred at March 14th 2023."
Share this study with friends
Copy Link
Messenger